Giardia Induced Fatigue and Functional Gastrointestinal Diseases (GIFF)
This study is enrolling participants by invitation only.
Sponsor:
University of Bergen
Information provided by:
University of Bergen
ClinicalTrials.gov Identifier:
NCT00860236
First received: March 11, 2009
Last updated: April 22, 2009
Last verified: April 2009
| Tracking Information | |
|---|---|
| First Received Date ICMJE | March 11, 2009 |
| Last Updated Date | April 22, 2009 |
| Start Date ICMJE | March 2009 |
| Estimated Primary Completion Date | May 2010 (final data collection date for primary outcome measure) |
| Current Primary Outcome Measures ICMJE |
Improvement minimum 6 points in Chalder Fatigue scale score [ Time Frame: 6 months ] [ Designated as safety issue: No ] |
| Original Primary Outcome Measures ICMJE | Same as current |
| Change History | Complete list of historical versions of study NCT00860236 on ClinicalTrials.gov Archive Site |
| Current Secondary Outcome Measures ICMJE | Not Provided |
| Original Secondary Outcome Measures ICMJE | Not Provided |
| Current Other Outcome Measures ICMJE | Not Provided |
| Original Other Outcome Measures ICMJE | Not Provided |
| Descriptive Information | |
| Brief Title ICMJE | Giardia Induced Fatigue and Functional Gastrointestinal Diseases |
| Official Title ICMJE | Chronic Fatigue Syndrome and Abdominal Symptoms After Giardia Infection: Clinical Evaluation, Biomarkers, Risk Factors and the Effect of Intervention |
| Brief Summary | A giardiasis outbreak in Bergen has given us the opportunity to approach two basic research questions of national and global importance:
|
| Detailed Description | Not Provided |
| Study Type ICMJE | Interventional |
| Study Phase | Phase 4 |
| Study Design ICMJE | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Condition ICMJE | Chronic Fatigue Syndrome |
| Intervention ICMJE |
|
| Study Arm (s) |
|
| Publications * | Not Provided |
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|
| Recruitment Information | |
| Recruitment Status ICMJE | Enrolling by invitation |
| Estimated Enrollment ICMJE | 40 |
| Estimated Completion Date | December 2010 |
| Estimated Primary Completion Date | May 2010 (final data collection date for primary outcome measure) |
| Eligibility Criteria ICMJE | Inclusion Criteria:
|
| Gender | Both |
| Ages | 18 Years and older |
| Accepts Healthy Volunteers | Yes |
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects |
| Location Countries ICMJE | Norway |
| Administrative Information | |
| NCT Number ICMJE | NCT00860236 |
| Other Study ID Numbers ICMJE | GIFF |
| Has Data Monitoring Committee | No |
| Responsible Party | Nina Langeland, Professor, University of Bergen |
| Study Sponsor ICMJE | University of Bergen |
| Collaborators ICMJE | Not Provided |
| Investigators ICMJE | Not Provided |
| Information Provided By | University of Bergen |
| Verification Date | April 2009 |
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|